Bleeding Disorders in 2035: Michael Makris is Future-Focused at HABIT Summit 2025
Brian O Mahony, CEO of Irish Haemophilia Society, posted in appreciation of Michael Makris on X:
”Professor Michael Makris giving his view on bleeding disorders treatment and comprehensive care in year 2035 at HABIT Summit 2025 in Osaka, Japan.”
While most of us are still figuring out how to schedule next week’s clinic, Professor Michael Makris is already living in 2035.
At the HABIT Summit 2025 held in Osaka, Japan, Professor Makris, a leading voice in hematology, delivered an insightful presentation on the projected state of bleeding disorders care in the year 2035.
With decades of experience in clinical practice and policy, he offered a forward-looking perspective on how treatment, patient management, and comprehensive care models are expected to evolve over the next decade.
Read Hemostasis Today, to not miss out on important in the field of thrombosis and hemostasis.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025